What is the primary objective of the joint research between DUMSCO and Kansai Medical University?

The primary objective is to analyze the usage data of the ePRO system 'Hakarute' to clarify correlations between patient backgrounds and frequently entered self-symptoms and QOL items.

What is 'ePRO' and why is it gaining attention in cancer treatment?

'ePRO' (electronic Patient Reported Outcome) involves patients reporting symptoms and quality of life (QOL) via smart devices, attracting attention for early side effect detection and survival period prolongation.

What are the identified challenges in implementing ePRO systems in clinical settings in Japan?

Challenges include addressing elderly patients, operational burden on healthcare staff, and insufficient detailed analysis of which patient groups and which items are effectively functioning.

What specific data will be provided for this joint research?

The joint research will utilize the ePRO 'Hakarute' dataset, which contains data on patient-reported outcomes.

What is the planned research period for this retrospective study?

The planned research period for this retrospective study is from December 1, 2025, to March 31, 2027.

AI News NQ Analysis

DUMSCO Commences Joint Research with Kansai Medical University on the Actual Usage of ePRO 'Hakarute'

NQ Score 56/100

Key facts

DUMSCO Commences Joint Research with Kansai Medical University on the Actual Usage of ePRO 'Hakarute'
DUMSCO and Kansai Medical University have begun joint research on the actual usage of the ePRO system 'Hakarute'.
Date: Mon Mar 30 2026 05:11:10 GMT+0900 (Japan Standard Time)

Direct answer

DUMSCO and Kansai Medical University have begun joint research on the actual usage of the ePRO system 'Hakarute'.

Citation: DUMSCO Commences Joint Research with Kansai Medical University on the Actual Usage of ePRO 'Hakarute' (Mon Mar 30 2026 05:11:10 GMT+0900 (Japan Standard Time)), PR TIMES
Source: PR TIMES
Date: Mon Mar 30 2026 05:11:10 GMT+0900 (Japan Standard Time)

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the primary objective of the joint research between DUMSCO and Kansai Medical University?: A: The primary objective is to analyze the usage data of the ePRO system 'Hakarute' to clarify correlations between patient backgrounds and frequently entered self-symptoms and QOL items.
Q: What is 'ePRO' and why is it gaining attention in cancer treatment?: A: 'ePRO' (electronic Patient Reported Outcome) involves patients reporting symptoms and quality of life (QOL) via smart devices, attracting attention for early side effect detection and survival period prolongation.
Q: What are the identified challenges in implementing ePRO systems in clinical settings in Japan?: A: Challenges include addressing elderly patients, operational burden on healthcare staff, and insufficient detailed analysis of which patient groups and which items are effectively functioning.
Q: What specific data will be provided for this joint research?: A: The joint research will utilize the ePRO 'Hakarute' dataset, which contains data on patient-reported outcomes.
Q: What is the planned research period for this retrospective study?: A: The planned research period for this retrospective study is from December 1, 2025, to March 31, 2027.